Maxime Descy
Corporate Strategy Manager at Curium Pharma | Brussels, Brussels Region, Belgium
Maxime Descy’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Maxime Descy serves as a Corporate Strategy Manager at Curium Pharma, a global leader in nuclear medicine developing radiopharmaceutical products for cancer diagnostics and treatment. He leverages his academic training from the Louvain School of Management to drive strategic initiatives that align with the organization’s clinical and commercial objectives. Operating from Brussels, he integrates management consulting frameworks into the pharmaceutical sector to advance corporate development efforts.
BEST APPROACH TO REACH Maxime Descy
Initiate outreach via personal email with a concise introductory note connecting your capabilities directly to Curium Pharma’s ongoing expansion in oncology and corporate strategy.
Corporate Strategy Manager at Curium Pharma in January 2026 - Present
Case Team Leader at Roland Berger in July 2025 - October 2025
Senior Consultant at Roland Berger in April 2024 - June 2025
Louvain School of Management, Msc, July 2026
Università Bocconi, July 2026
Université de Namur, BSc, July 2026
Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation. We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have. As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing. Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians. Our Promise We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.
Discover more about Curium PharmaQuality Control Manager at Curium Pharma
Quality Control Manager at Curium Pharma
(July 2025 – Present)
M&A | BD&L | Corporate Strategy (Healthcare & Life Sciences)
Director of Business Development at Curium Pharma
(August 2025 – Present)
Director of Clinical Operations at Curium Pharma/ Prostate Cancer
Director of Clinical Operations at Curium Pharma
(September 2021 – Present)
Regulatory Affairs, MSc. Chemical Engineer
Regulatory Affairs Specialist at Curium Pharma
(May 2023 – Present)
Chemical Engineer
Junior Quality Control Specialist at Curium Pharma
(December 2025 – Present)
Senior Director - R&D Curium Pharma
Senior Director R&D at Curium Pharma
(July 2025 – Present)
What is Maxime Descy email address?
Email Maxime Descy at [email protected] and [email protected]. This email is the most updated Maxime Descy's email found in 2026.
How to contact Maxime Descy?
To contact Maxime Descy send an email to [email protected] or [email protected]. (updated on March 11, 2026)
What company does Maxime Descy work for?
Maxime Descy works for Curium Pharma.
What is Maxime Descy's role at Curium Pharma?
Maxime Descy is Corporate Strategy Manager
What industry does Maxime Descy work in?
Maxime Descy works in the Management Consulting industry.